News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

National Health Council to Host Workshop for Patient Organizations
MDedge Hematology and Oncology
Abstracts Being Accepted for Cornelia de Lange Syndrome Foundation Symposium
MDedge Hematology and Oncology
MDS Foundation Hosts Family/Caregiver Forums
MDedge Hematology and Oncology
‘Right to try’ bill passes House
MDedge Hematology and Oncology
Think about breast cancer surveillance for transgender patients
MDedge Hematology and Oncology
Lenalidomide yields responses in a rare cutaneous lymphoma
MDedge Hematology and Oncology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Hematology and Oncology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Hematology and Oncology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Hematology and Oncology
RFPs Available for the Study of Three Rare Diseases
MDedge Hematology and Oncology